BioHarvest Sciences Operating Margin 2020-2024 | BHST
Current and historical operating margin for BioHarvest Sciences (BHST) over the last 10 years. The current operating profit margin for BioHarvest Sciences as of June 30, 2024 is -84.84%.
| BioHarvest Sciences Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2024-06-30 |
$0.02B |
$-0.01B |
-42.11% |
| 2024-03-31 |
$0.02B |
$-0.01B |
-56.25% |
| 2023-12-31 |
$0.01B |
$-0.01B |
-84.62% |
| 2023-09-30 |
$0.01B |
$-0.01B |
-110.00% |
| 2023-06-30 |
$0.01B |
$-0.01B |
-133.33% |
| 2023-03-31 |
$0.01B |
$-0.01B |
-157.14% |
| 2022-12-31 |
$0.01B |
$-0.01B |
-183.33% |
| 2022-09-30 |
$0.01B |
$-0.01B |
-180.00% |
| 2022-06-30 |
$0.00B |
$-0.01B |
-225.00% |
| 2022-03-31 |
$0.00B |
$-0.01B |
-300.00% |
| 2021-12-31 |
$0.00B |
$-0.01B |
-400.00% |
| 2021-09-30 |
$0.00B |
$-0.01B |
-900.00% |
| 2021-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2021-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2020-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2020-06-30 |
$0.00B |
$-0.00B |
inf% |
| 2020-03-31 |
$0.00B |
$-0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
